some 6, are important determinants of the IgA-mediated immune response, and HLAs are probably involved in the pathogenesis of pIgAN [6] . HLAs are highly polymorphic transmembrane glycoproteins composed of an ␣ and a ␤ subunit and are expressed on the surface of B lymphocytes, macrophages/monocytes and some T lymphocytes [7] . The genes encoding the 3 major expressed class II products are arranged in 3 main subregions: DP, DQ and DR. IgA antibody-mediated response is T cell dependant, and the HLA class II products encoded by the DP, DQ and DR genes are considered to play a crucial role in the presentation of processed antigen to specific T cells [8] . A number of alleles of these genes have been reported. Therefore, the class II allelic polymorphism of the HLA gene may affect the pathogenesis of pIgAN.
An early study by Tolkoff-Rubin et al. [9] demonstrated that pIgAN was in association with allelic variation of HLA genes. In the past decades, there were many clinical studies which provided further evidence indicating a marked association of HLA gene polymorphism and pIgAN [2] [3] [4] [5] . Earlier studies have shown that HLA-DR * 4 might be associated with pIgAN, especially in Japanese [10] [11] [12] [13] and Chinese patients [14] . There is a significant association between HLA-DQB1 * 0301 and IgAN patients with a poor clinical outcome [15] . DR * 12 is also associated with pIgAN in Chinese patients [16] . However, studies in Hong Kong [17] and Taiwan [18] did not reveal any association between HLA-DR and pIgAN. It appears that this association exists only in French Caucasians [19] , while other studies failed to show a significant association between HLA class II alleles and IgAN [8] .
HLA-DRB1, approximately 26-28 kDa, is encoded by 6 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the 2 extracellular domains, exon 4 encodes the transmembrane domain, and exon 5 encodes the cytoplasmic tail. Within the DR molecule, the ␤ chain contains all the polymorphisms specifying the peptide-binding specificities. Hundreds of DRB1 alleles have been identified, and typing of these polymorphisms is routinely conducted for organ (bone marrow and kidney) transplantation. Studies have shown that several alleles at the HLA-DRB1 locus were associated with susceptibility to pIgAN [20] . The incidence of HLA-DRB1 * 08 in patients with a family history of IgA nephropathy is higher than sporadic IgA nephropathy [20] . However, data are scant on the relationship of HLA-DRB1 alleles and IgAN in Chinese. In the present study, the association of the HLA-DRB1 locus with the predisposition and disease progression in Han Chinese patients with pIgAN was investigated.
Methods

Patients and Healthy Subjects
Patients were recruited from the Department of Nephrology, the First Affiliated Hospital of Sun Yat-sen University in Guangzhou, China. A total of 139 patients (age, 33.1 8 12.2 years; sex, 62 males and 77 females) with pIgAN were enrolled in this study. The diagnosis of pIgAN was confirmed by histological and immunological examinations following renal biopsy and met the diagnostic criteria of the World Health Organization [21] . Renal histological lesions of pIgAN patients were evaluated by 2 independent pathologists using the scoring system as described by Haas [22] . All patients underwent detailed medical and biochemical examinations. Patients with systemic diseases such as diabetes, chronic liver disease and systemic lupus erythematosus were excluded. Pregnant women were also excluded.
In addition, 143 healthy gender-and age-matched unrelated subjects with no history of renal disease or hypertension were also recruited on a voluntary basis from Guangdong province (Guangzhou, China). The ethics approval of the study was obtained from the Ethics Committee of the First Affiliated Hospital of Sun Yatsen University (Guangzhou, China), and all participants provided informed consents. 
DNA Extraction
Venous blood samples were obtained from the participants. The genomic DNA was extracted from peripheral blood lymphocytes by using QIAamp DNA Blood Midi Kit (Qiagen, Hilden, Germany), according to the manufacturer protocol.
HLA-DRB1 Genotyping
The polymorphisms of exon 2 of the HLA-DRB1 gene were determined by PCR-based sequencing technique, as described previously [23] . Some alleles (DRB1 * 140101 and DRB1 * 1454; DRB1 * 120101 , DRB1 * 1206 and DRB1 * 1210; DRB1 * 040601 and DRB1 * 040602), which have the same sequences in the second exon region, were unable to be distinguished by the method. We designated them as groups of alleles: DRB1 * 140101/1454, DRB1 * 120101/1206 /1210 and DRB1 * 040601/040602. Statistical Analysis HLA-DRB1 allele frequencies were calculated by direct counting method. Agreement with Hardy-Weinberg equilibrium was tested for genotype frequencies in the healthy subjects by using PyPop statistical software [24] . The frequency distribution of HLA-DRB1 alleles in patients and healthy subjects was compared by the 2 test employing a Fisher's exact 2-tailed test where appropriate, and the odds ratios (ORs) and 95% confidence intervals (CIs) for individuals with a specific genotype were calculated by the methods of Woolf [25] . p ! 0.05 was considered statistically significant. Corrected p value (p ) was obtained by multiplying the p value by the number of alleles tested for each locus according to Bonferroni's correction method [26] . Demographic and clinical data between groups were compared by Student's t test. SPSS version 11.0 for Windows (SPSS, Chicago, Ill., USA) was used for all statistical analyses.
Results and Discussion
The demographics of the IgAN patients and healthy controls enrolled in this study are shown in table 1 . There were no significant differences between the patients and healthy controls with regard to mean age or gender distribution. One hundred and thirty-two of 139 pIgAN patients had completely recorded clinical data. Meanwhile, the patients whose renal glomerular number was less than 10 in the renal biopsy sample were excluded from the Haas grade, added up to 23.
Allele frequencies of the HLA-DRB1 gene in pIgAN patients and healthy subjects in Han Chinese are summarized in table 2 . Up to 37 different alleles were detected, of which 30 were found in pIgAN patients while 29 were observed in healthy subjects. The frequencies of HLA-DRB1 * 140101 and * 140501 were significantly increased in the patients compared with healthy subjects The pIgAN patients were divided into different subgroups for further stratification analysis, based on blood pressure (according to the standard of hypertension of WHO-ISH in 1999), 24-hour content of urine protein ( 6 1 or ! 1 g/24 h), serum IgA level ( 1 3.45 or ^ 3.45 mmol/l), gross hematuria (positive or negative), renal function (glomerular filtration rate 1 60 or ^ 60 ml/min), and renal histological lesions (evaluated by 2 independent pathologists using the Haas scoring system). Table 3 shows the allele frequencies of the HLA-DRB1 gene in patients with hypertension and in patients with normal blood pressure. The frequency of HLA-DRB1 * 150101 was significantly higher in patients with hypertension than in patients with normal blood pressure (OR = 2.218, 95% CI 1.010-4.872, p = 0.043, p = 1.290). Table 4 shows allele frequencies of the HLA-DRB1 gene in patients with normal or abnormal serum IgA level. The frequency of HLA-DRB1 * 090102 was significantly lower in patients with an abnormal serum IgA level than in patients with a normal Table 5 shows the allele frequencies of the HLA-DRB1 gene between patients with or without gross hematuria. The frequency of HLA-DRB1 * 120101 and * 120201 in patients with gross hematuria was significantly higher than in patients without gross hematuria ( DRB1 * 120101: OR = 6.825, 95% CI 1.473-31.617, p = 0.021, p = 0.630; DRB1 * 120201: p = 0.038, p = 0.114). The distribution of HLA-DRB1 alleles in patients with normal renal function or renal insufficiency is listed in table 6 . The frequencies of HLA-DRB1 * 030101 and * 040601 in patients with normal renal function were significantly higher than in patients with renal dysfunction ( DRB1 * 030101: OR = 5.654, 95% CI 2.317-13.794, p ! 0.0005, p ! 0.015; DRB1 * 040601: OR = 8.033, 95% CI 1.520-42.451, p = 0.012, p = 0.360). However, there was no significant difference in the frequencies of the HLA-DRB1 gene when the patients were grouped by other variables.
HLA-DR is the most polymorphic locus in humans, in which over 450 HLA-DRB1 alleles (http://www.ebi.ac.uk/ imgt/hla) have so far been detected [27, 28] . To date, 3,628 single nucleotide polymorphisms of the HLA-DRB1 gene have been identified, many of them being non-synonymous (http://www.ncbi.nlm.nih.gov/sites/entrez, access date, 11 February 2008) . Based on sequence similarity and serological specificity, most of the HLA-DRB1 alleles can be divided into 13 allelic lineages (denoted * 01, * 03, * 04, * 07, * 08, * 09, * 10, * 11, * 12, * 13, * 14, * 15 and * 16 ) [29] . HLA class II gene polymorphisms have been implicated in the occurrence and disease progression of pIgAN patients [4] . The present study has shown that HLA-DRB1 * 140501 (belonging to DR * 14 ) and HLA-DRB1 * 070101 (belonging to DR * 7 ) alleles are associated with IgAN in Han Chinese. The higher frequency of DR * 14 in pIgAN patients suggests that DR * 14 might be a susceptible allele, while DR * 7 might be resistant alleles, as evidenced by their significantly lower frequencies in pIgAN patients compared with healthy subjects.
In the current study, we found that frequencies of HLA-DRB1 * 030101 in patients with normal renal function were significantly higher than in patients with renal inadequacy, which is different from that found in Japanese patients [10] . The reason for this is unknown, but may be associated with ethnic differences in altered immune responses in IgAN. In the past 2 decades, the association of HLA-DRB1 alleles and pIgAN has been studied in various ethnic groups [10] [11] [12] [13] [14] . In Japanese and French [19] cohorts, there was a strong association between pIgAN and the HLA-DR4 gene; a study of Japanese patients found that some haplotypes of the HLA-DRA locus had an important role in the development of pIgAN [30, 31] . Notably, HLA-DR * 12 was associated with pIgAN in northern Chinese, while HLA-DR * 4 was associated with pIgAN in eastern Chinese [14] . However, there was no association between the HLA-DRB1 gene and pIgAN in European Caucasians [8] , and there was no association between HLA-DR and pIgAN in Chinese of Hong Kong [17] and Taiwan [18] . In contrast to these results, our study found that the polymorphisms of the HLA-DRB1 gene were significantly associated with pIgAN in Han Chinese. Such a marked discrepancy may be attributed to racial differences in the genetic background of cohorts from different ethnic groups and differential interplay of IgAN susceptibility genes with environmental factors. Since haplotypes are a better predictor than individual genetic mutations for disease susceptibility, further studies are warranted to explore the association of haplotypes of HLA class II genes with IgAN. Newer techniques are presently being developed, such as high-density single nucleotide polymorphism genome-wide scanning, which will hopefully result not only in better screening of individuals at highest risk, but also in novel therapeutic approaches.
The association of HLA-DRB1 alleles with the disease severity when indicated by renal function of IgAN suggests that disease-associated HLA-DRB1 alleles are similar but not identical, and certain allelic variants are preferentially enriched in specific patient populations with defined clinical characteristics. This also suggests a gene dosing effect of HLA-DRB1 alleles. Therefore, polymorphisms in HLA class II genes can be explored as tools to identify high-risk individuals and to dissect the clinical heterogeneity of IgAN.
Our study indicated that several allelic variants of the HLA-DRB1 gene have been associated with IgAN, sup- IgA usually helps the body to fight infections and toxins encountered in the gut and the lungs, but it is still not understood why IgA is deposited in the kidneys. A number of immunosuppressant drugs have been tested on their own and in combination, but there is little evidence of definite benefit for IgAN so far.
In conclusion, our study indicates that polymorphisms of the HLA-DRB1 gene may be a useful marker associated with the susceptibility of pIgAN in Han Chinese, and HLA-DRB1 * 140501 might be a susceptible allele, while HLA-DRB1 * 070101 might be resistant alleles. Studies are warranted to explore the immunological mechanisms for the genotype-disease phenotype association. Further family-based studies are needed to test whether these genetic risk markers confer an effect or whether it is due to other variants nearby with which they are in linkage disequilibrium (e.g., haplotypes). 
